Viewing Study NCT00068250


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-04 @ 8:44 AM
Study NCT ID: NCT00068250
Status: COMPLETED
Last Update Posted: 2018-02-07
First Post: 2003-09-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Sponsor: Radiation Therapy Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: RTOG-0227
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None OTHER View